Key result
Fibrinolysis shutdown and hypofibrinolysis represent distinct pathophysiological entities and should not be used interchangeably.
Why the study?
Interchanging the terms hypofibrinolysis and fibrinolysis shutdown to describe critically ill patients impairs understanding of disease pathophysiology, alongside a lack of research on their cellular mediators.
Differentiating between hypofibrinolysis and fibrinolysis shutdown is important for understanding the pathophysiology of low fibrinolytic states in critically ill patients.
Low fibrinolytic activity has been associated with pathologic thrombosis and multiple-organ failure. Low fibrinolytic activity has two commonly associated terms, hypofibrinolysis and fibrinolysis shutdown. Hypofibrinolysis is a chronic state of lack of ability to generate an appropriate fibrinolytic response when anticipated. Fibrinolysis shutdown is the shutdown of fibrinolysis after systemic activation of the fibrinolytic system. There has been interchanging of these terms to describe critically ill patients in multiple settings. This is problematic in understanding the pathophysiology of disease processes related to these conditions. There is also a lack of research on the cellular mediators of these processes. The purpose of this article is to review the on and off mechanisms of fibrinolysis in the context of low fibrinolytic states to define the importance in differentiating hypofibrinolysis from fibrinolysis shutdown. In many clinical scenarios, the etiology of a low fibrinolytic state cannot be determined due to ambiguity if a preceding fibrinolytic activation event occurred. In this scenario, the term "low fibrinolytic activity" or "fibrinolysis resistance" is a more appropriate descriptor, rather than using assumptive of hypofibrinolysis and fibrinolysis shutdown, particularly in the acute setting of infection, injury, and surgery.
No takes yet. Share an insight, caveat, or question.
Hunter B. Moore (2022) conducted a review in Low fibrinolytic states. Fibrinolysis shutdown, which occurs after systemic activation, and hypofibrinolysis, a chronic inability to mount a response, are distinct pathophysiological processes that should not be used interchangeably.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: